Ablynx CEO Dr. Edwin Moses Video Interview: How We Built a 25-Compound Pipeline
(Thomson Reuters ONE) -
In an exclusive video interview with PropThink.com, Ablynx (EBR:ABLX)(OTC:ABLYF)
CEO Dr. Edwin Moses discusses the company's platform Nanobody technology -
1/10th the size of traditional anti-bodies - and the broad indications in which
their compounds may prove beneficial. Ablynx has created a unique development
and production strategy that relies on partnership agreements - Merck Serono
(NYSE:MRK), Novartis (NYSE:NVS) - for commercialization of their products. The
company has raised more than ?200M in equity financing and over ?160M through
partnership milestones and royalties, but has no commercial arm of their own.
Dr. Moses says the company has one orphan drug that they may take through
commercialization alone - a first - and 25 projects in various stages of
pipeline development. He discusses the importance of intellectual property for
Ablynx and the company's promising Phase I pulmonary product that he believes
may be a first of its kind.
Click here to see the full video interview with Dr. Moses and Ablynx.
About PropThink
PropThink is an intelligence service that delivers long and short trading ideas
to investors in the healthcare and life sciences sectors. Our focus is on
identifying and analyzing technically-complicated companies and equities that
are grossly over or under-valued. We offer daily market coverage, weekly feature
stories, and a newsletter to investors who subscribe on PropThink.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: PropThink via Thomson Reuters ONE
[HUG#1625214]
Unternehmensinformation / Kurzprofil:
Datum: 09.07.2012 - 13:53 Uhr
Sprache: Deutsch
News-ID 163299
Anzahl Zeichen: 2127
contact information:
Town:
New York
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 116 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ablynx CEO Dr. Edwin Moses Video Interview: How We Built a 25-Compound Pipeline"
steht unter der journalistisch-redaktionellen Verantwortung von
PropThink (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
